35 related articles for article (PubMed ID: 1704638)
1. Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine.
Levenson VJ; Mallett CP; Hale TL
Infect Immun; 1995 Jul; 63(7):2762-5. PubMed ID: 7790095
[TBL] [Abstract][Full Text] [Related]
2. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.
Levenson VI; Egorova TP; Belkin ZP; Fedosova VG; Subbotina JL; Rukhadze EZ; Dzhikidze EK; Stassilevich ZK
Infect Immun; 1991 Oct; 59(10):3610-8. PubMed ID: 1716612
[TBL] [Abstract][Full Text] [Related]
3. [A protective factor of ribosomal shigellosis vaccine].
Levenson VI; Rukhadze EZ; Egorova TP; Belkin ZP; Fedosova VG
Zh Mikrobiol Epidemiol Immunobiol; 1988 Jul; (7):50-4. PubMed ID: 3055762
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
[TBL] [Abstract][Full Text] [Related]
5. [O-specific L-hapten in the composition of Shigella sonnei].
Egorova TP; Sazykina SIu; Fedosova VG; Lebenson VI
Zh Mikrobiol Epidemiol Immunobiol; 1989 Nov; (11):8-13. PubMed ID: 2482642
[TBL] [Abstract][Full Text] [Related]
6. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants].
Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME
Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharide nature of O antigen in protective ribosomal preparations from Shigella: experimental evidence and implications for the ribosomal vaccine concept.
Levenson VI; Egorova TP
Res Microbiol; 1990; 141(6):707-20. PubMed ID: 1704638
[TBL] [Abstract][Full Text] [Related]
8. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.
Robbins JB; Chu C; Schneerson R
Clin Infect Dis; 1992 Aug; 15(2):346-61. PubMed ID: 1381621
[TBL] [Abstract][Full Text] [Related]
9. Classical and novel strategies to develop a
Barel LA; Mulard LA
Hum Vaccin Immunother; 2019; 15(6):1338-1356. PubMed ID: 31158047
[No Abstract] [Full Text] [Related]
10. Pathogenesis and immunology in shigellosis: applications for vaccine development.
Hale TL; Keren DF
Curr Top Microbiol Immunol; 1992; 180():117-37. PubMed ID: 1380415
[No Abstract] [Full Text] [Related]
11. Genetic determinants of virulence in Shigella and dysenteric strains of Escherichia coli: their involvement in the pathogenesis of dysentery.
Kopecko DJ; Baron LS; Buysse J
Curr Top Microbiol Immunol; 1985; 118():71-95. PubMed ID: 2414072
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
